Dr. Mary K. Crow, MD

Dr. Crow practices at Saint Alphonsus Medical Center - Nampa in Nampa, Idaho, part of Trinity Health.

Dr. Crow's NPI, 1164425211, was assigned on May 23, 2005. Dr. Crow graduated from Baylor College Of Medicine in 1989. Dr. Crow holds Texas license H7624.

Dr. Crow's primary practice is Saint Alphonsus Medical Center - Nampa, at 4300 E Flamingo Ave, Nampa, ID 83687 in Canyon County. The practice phone is (208) 463-5000.

Dr. Crow's primary practice is Saint Alphonsus Medical Center - Nampa in Nampa, Idaho, part of Trinity Health. Dr. Crow is also affiliated with Saint Alphonsus Regional Medical Center. The medical group on file is Saint Alphonsus Regional Medical Center. Dmand AI also links Dr. Crow to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crow practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Crow's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Crow is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Crow's licenses on file in 5 states: Texas, Idaho, Utah, Montana and Wyoming.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Crow treats.

CMS data shows 96 Medicare services from Dr. Crow across 3 procedure codes in 2024, all of them office visits, for 68 Medicare patients. Medicare paid $4,515 for them.

CMS counts 68 Medicare patients who saw Dr. Crow in 2024. The largest group is 75 to 84, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crow's median patient age at 71, with 60% women.

In 2024, Dr. Crow wrote 708 Medicare Part D claims for 241 patients. 80% of them were for generic drugs. CMS names the drug for 369 of them, across 15 drugs with 11 or more claims each, at $59,507 in total drug cost. In 2023, CMS named 2,230 claims across 62 drugs.

Dr. Crow accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Crow. Dr. Crow's most frequent co-authors are Joseph Chao, MD, Frank J.y. Hsu, MD and Bridget Keenan.

Dmand AI links Dr. Crow to 3 clinical trials. Conditions studied include Breast Neoplasms, Breast Diseases and Urethral Neoplasms. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Crow that name 3 trials.

CMS Open Payments shows 1,666 general payments to Dr. Crow from 96 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,259. It also lists 4 research payments totaling $1,181 from 2016 to 2019, naming 3 clinical trials.

Dmand AI lists 2 awards for Dr. Crow, most recently CMS Stage 1 2012 in 2011.

Dr. Crow graduated from Baylor College Of Medicine in 1989. Dr. Crow is a member of ASCO.

Dr. Crow is in network with 22 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.